We're investing over £280,000 to accelerate the development of new Parkinson's drugs
Date
News
Date
The simple skin test was able to detect a troublesome protein associated with Parkinson's and other similar conditions.
Date
Our latest round of grants fund projects which aim to improve everyday life for people living with Parkinson's, without the need for extra medications.
Date
Patient groups, healthcare professionals and NHS England came together to take action to ensure people in hospital get their medication on time, every time.
Date
We're teaming up with Walking Football Scotland to give people with Parkinson's more opportunities to play the game.
Date
Foslevodopa-foscarbidopa (also called Produodopa) has been approved by NICE in England, Northern Ireland and Wales and the Scottish Medicines Consortium for people with Parkinson's who experience movement related symptoms.
Date
Foslevodopa-foscarbidopa (also called Produodopa) can be offered in England from 27 February for people with Parkinson's who experience movement related symptoms.
Date
Produodopa, a groundbreaking new treatment for advanced Parkinson's, can now be prescribed in Scotland.
Date
A further trial of a device-delivered GDNF is not going ahead, but other approaches are showing promise.
Date
At the end of March, the government's cost of living support will come to an end. Yet our new research has found that for many people with Parkinson's, the cost of living crisis is far from over.
Date
Predict-PD is a study that aims to understand the risk factors of Parkinson's. More than 10,000 people are now taking part and are representative of the ethnic diversity within the UK population.